CURRICULUM VITAE NAME Lynn A. Jansen, PhD … A. Jansen, PhD CURRICULUM VITAE NAME Lynn A. Jansen, PhD DATE August 16, 2017 PRESENT POSITION AND ADDRESS Academic Rank: Madeline Brill

Lynn A. Jansen, PhD

CURRICULUM VITAE

NAME

Lynn A. Jansen, PhD

DATE

August 16, 2017

PRESENT POSITION AND ADDRESS

Academic Rank:

Madeline Brill Nelson Chair in Ethics Education

&

Associate Professor

Department /

Division:

Internal Medicine/Ethics

Professional

Address:

The Center for Ethics in Health Care

Oregon Health & Science University

3181 S.W, Sam Jackson Park, Rd (UHN-86)

Portland, Oregon 97238 E-Mail Address:

[email protected]

I. EDUCATION

Undergraduate and Graduate (Include Year, Degree, and Institution):

1997 Ph.D. Columbia University, Political Science (Political Theory)

1995 M. Phil. Columbia University, Political Science (Political Theory)

1991 MA. Columbia University, Political Science (Political Theory)

1989 BA. Nova Southeastern University, Political and Legal Studies

1987 AS. Broward Community College, Nursing (RN)

Postgraduate (Include Year, Degree, and Institution):

2000 Ethics Fellow University of Chicago MacLean Center for Clinical Medical Ethics.

Licenses (Include State, Date, Status, Number, and Renewal Date):

Registered Professional Nurse Oregon-201142347RN- 2018

https://osbn.oregon.gov/OSBNVerification/Details.aspx?person=f2eec439-c82e-e011-93c8-005056bb0001

CV 08/16/17 Lynn A. Jansen, PhD 2

II. PROFFESIONAL EXPERIENCE Academic (Include Year, Position, and Institution):

2010-present Madeline Brill Nelson Chair in Ethics Education, The Center for Ethics in Health

Care, Oregon Health & Science University, Portland, OR

2010-present Member of Knight’s Cancer Prevention and Control Program, Knight Cancer

Institute, Oregon Health & Science University, Portland, OR

2010-present Associate Professor, Department of Internal Medicine & Geriatrics, Oregon

Health &Science University, Portland Oregon

2006-2010 Associate Research Professor of Medicine, Department of Medicine, New York

Medical College, Valhalla, NY

2000-2006 Assistant Research Professor of Medicine, Department of Medicine, New York

Medical College, Valhalla, NY

1999-2000 Fellow, MacLean Center for Medical Ethics University of Chicago, Chicago, IL

1996 Adjunct Assistant Professor, Department of Political Science, Dowling College,

Long Island, NY

1992-1994 Preceptor, Department of Political Science, Columbia University, New York, NY

Administrative (Include Year, Position, and Institution):

2010-Present Associate Director, The Center for Ethics in Health Care, Oregon Health &

Science University, Portland, OR

2009-2010 Executive Director, The Bioethics Institute, New York Medical College,

Valhalla, NY

Oct. 2009 Executive Director and Chair, The John J. Conley Center for Ethics, St.

Vincent’s Hospital, NY

May 2009-Oct 2009 Acting Chair, John J. Conley Department of Ethics, St. Vincent’s Hospital, NY

2000-2010 Assistant Director, The Bioethics Institute, New York Medical College, Valhalla,

NY

III. SCHOLARSHIP

Area(s) of Research/Scholarly Interest:

Clinical Ethics

Research Ethics Ethics Education

Grants and Contracts: Federal (Include Title, Source, PI, Amount, Period)

July 2012- May 2018 Principal Investigator, Lynn A. Jansen “Understanding

Therapeutic Optimism and its Impact on Risk/Benefit

Assessment,” NIH-NCI GRANT #1 R01CA166556. $1,200,000


January 2015-January 2016 Principal Investigator, Lynn A. Jansen, “The Normative

Significance of the Optimistic Bias for Informed Consent to

Clinical Research,” Greenwall Foundation. $59,125.00

July 2008-June, 2011 Principal Investigator, Lynn A. Jansen “Understanding

Optimism in Clinical Research,” NIH-NCI GRANT #1 R21

CA131601. $250,000

Peer-Reviewed Publications:

Books:

1) Jansen, Lynn A. (2006) Death in the Clinic. Landham, Md. Rowman & Littlefield.

Articles: 1) Jansen, Lynn A. “Assessing Clinical Pragmatism,” Kennedy Institute of Ethics Journal (March, 1998)

Vol.8, No.1:25-36.

2) Jansen, Lynn A. and Lainie Friedman Ross, “Patient Confidentiality and the Surrogate’s Right to

Know,” Journal of Law, Medicine and Ethics (Summer, 2000) Vol. 28, No. 2:125-137.

3) Jansen, Lynn A. “The Virtues in their Place: Virtue Ethics and Medicine,” Theoretical Medicine and

Bioethics (October, 2000) Vol.21, No.8:261-276.

4) Jansen, Lynn A. “Deliberative Decision Making and the Treatment of Pain,” Journal of Palliative

Medicine (Spring, 2001) Vol. 4, Number 1: 23-31.

5) Jansen, Lynn A and Lainie Friedman Ross, “The Ethics of Pre-Adoption Genetic Testing,” The

American Journal of Medical Genetics (October, 2001) Vol. 104: 214-220.

6) Lebovits, A.H., Zenetos, P., O’Neill, D.K., Cox, D., Dubois, M.Y., Jansen, L.A. and Turndorf, H.

“Satisfaction with epidural and intravenous patient controlled analgesia.” Pain Medicine 2: (2001).

7) Jansen, Lynn A. “Ethical Concerns about the Detection and Treatment of Ovarian Cancer,”

Gynecologic Oncology, (2002) Vol. 84: 1-3.

8) Jansen, Lynn A. “Evil, Forgiveness and the Moral Community,” National Catholic Bioethics

Quarterly (Spring, 2002) 21-25. *Received Honorable Mention for best scholarly article from

National Catholic Bioethics Quarterly.

9) Jansen, Lynn A. and Daniel P. Sulmasy. “Sedation, Alimentation and Equivocation: Careful

Conversation about Care at the End of Life.” The Annals of Internal Medicine (June 4, 2002) Vol. 136:

845-849.


10) Jansen, Lynn A. and Daniel P. Sulmasy. “Proportionality, Suffering and The Restorative Goals of

Medicine,” Theoretical Medicine and Bioethics (2002) Vol. 23: 321-337.

11) Jansen, Lynn A. “The Moral Irrelevance of Proximity to Death.” Journal of Clinical Ethics (2003)

14: 49-58.

12) Jansen, Lynn A. and Daniel P. Sulmasy. “Bioethics, Conflicts of Interest and The Limits of

Transparency,” The Hastings Center Report. (July-August, 2003) 33: 40-43.

13) Jansen, Lynn A. “Child Organ Donation, Family Autonomy and Intimate Attachments.” Cambridge

Quarterly of Healthcare Ethics, 13 (2004) 133-141. *Reprinted in Bioethics in a Changing World, eds.

Jennifer Parks and Victoria Wilkes. (Prentice Hall, 2009).

14) Jansen, Lynn A. “No Safe Harbor: The Problem of Complicity and the Practice of Voluntary

Stopping of Eating and Drinking,” The Journal of Medicine and Philosophy, 29 (Feb 2004) 61-75.

*Reprinted in Current Controversies: Suicide, ed. Paul Connors. (Greenhaven Press, 2007).

15) Jansen, Lynn A. “On Self-Determination, Care by Proxy, and New Techniques,” Pain Medicine

(March, 2004) 5: 94-95.

16) Jansen, Lynn A. “Ethical and Legal Considerations in Adoption Referral for Physicians.” American

College of Physicians PIER Module. (April, 2004) available on line at: http://pier.acponline.org

17) Jansen, Lynn A. “HIV Exceptionalism, CD4+ Cell Testing, and Conscientious Subversion,” Journal

of Medical Ethics (June 2005) 31: 322-326.

18) Jansen, Lynn A. “Local IRBs, Multi-Center Trials, and The Ethics of Internal Amendments," IRB:

Ethics and Human Research (July –August, 2005) 7-11.

19) Jansen, Lynn A. “A Closer Look at The Bad Deal Trial: Beyond Clinical Equipoise.” The Hastings

Center Report (2005) Vol. 35, No.5:29-36.

20) Jansen, Lynn A. “Hastening Death and the Boundaries of the Self.” Bioethics (2006) Vol. 20,

No.2:105-111.

21) Jansen, Lynn A. “The Problem with Optimism in Clinical Trials," IRB: Ethics and Human Research

(July-August, 2006) 13-19.

22) Jansen, Lynn A. and Steven Wall, “Paternalism and Fairness in Clinical Research,” Bioethics

(March, 2009) 172-182.

23) Jansen, Lynn A. “Consensus and Independent Judgment: Or What Can an 18TH Century

Mathematician Teach Us About Ethics Consultation,” The Journal of Clinical Ethics (Spring, 2009) Vol.

20:56-63.

24) Jansen, Lynn A. “The Ethics of Altruism in Clinical Research,” The Hastings Center Report (July-

August 2009) Vol. 39:26-36. *With a response/comment by Nancy M.P.King “Benefits, Harms, and

Motives in Clinical Research.”

http://pier.acponline.org/


25) Jansen, Lynn A. “Disambiguating Clinical Intentions: The Ethics of Palliative Sedation,” The

Journal of Medicine and Philosophy (January, 2010):1-13.

26) Jansen, Lynn A. and Jessica S. Fogel. “Ascribing Intentions in Clinical Decision-Making,” Journal

of Medical Ethics (January, 2010):2-6.

27) Jansen, Lynn A. Appelbaum Paul, Klein William MP, Weinstein, Neil D, Cook William, Fogel

Jessica S, Sulmasy, Daniel P. “Unrealistic Optimism in Early Phase Oncology Trials,” IRB: Ethics and

Human Research, (January-February, 2011):1-8.**Article received national media attention.

Reported on in The New York Times, The Wall Street Journal, MSNBC, The LA Times, and

JAMA and ASCO Post.

28) Jansen, Lynn A. “Two Concepts of Therapeutic Optimism,” The Journal of Medical Ethics

2011;37:563-566.

29) Jansen, Lynn A. “Consent, Exploitation, and Autonomy in Clinical Research,” in Theoretical and

Applied Ethics (Spring, 2011):32-34.

30) Jansen, Lynn A., Jessica S. Fogel and Mark Brubaker. “Experimental Philosophy, Clinical Intentions

and Evaluative Judgment,” Cambridge Quarterly Journal of Health Care Ethics (2013), 22, 1-10.

31) Jansen, Lynn A. “Between Beneficence and Justice: The Ethics of Stewardship in Medicine," The

Journal of Medicine and Philosophy (January, 2013) 38;1:50-63.

32) Jansen, Lynn A. "Stewardship." Bioethics. Ed. Bruce Jennings. 4th ed. Vol. 6. Farmington Hills, MI:

Macmillan Reference USA, 2014. 3011-3016. (Gale Virtual Reference Library. Web. 25 June 2014

Encyclopedia of Bioethics.)

33) Jansen, Lynn A and Steven Wall. “Rethinking Exploitation: A Process-Centered Account,” Kennedy

Institute of Ethics Journal 23(4) 2013:381-410.

34) Jansen, Lynn A. “Mindsets, Informed Consent and Research,” The Hastings Center Report

44(2014);25-32. *With responses from Paul Appelbaum, Charles Lidtz, Steven Joffe and Jennifer

W. Mack.

35) Jansen, Lynn A. and Eran Klein. “Consent Through Rose-Tinted glasses: The Optimistic Bias in

Parkinson’s Disease Clinical Trials,” American Journal of Bioethics/Neuroscience. 6 (1):1-3, (2015).

36) Jansen, Lynn A. "The Optimistic Bias and Illusions of Control in Clinical Research," IRB: Ethics and

Human Research. March/April, 2016.

37) Jansen, Lynn A. “Taking Respect Seriously: Clinical Research and the Demands of Informed

Consent,” The Journal of Medicine and Philosophy, accepted October, 2016 (In press).

38) Jansen, Lynn A. Daruka Mahadevan, Paul S. Appelbaum, Jansen, Lynn A., Paul S. Appelbaum,

William MP Klein, Neil D. Weinstein, Motomo Mori, Catherine Degnin and Daniel P. Sulmasy. “Dispositional Optimism and Therapeutic Expectations in Early Phase Oncology Trials,” Cancer Feb

2016 (DOI: 10.1002/cncr.29908).


39) Jansen, Lynn A., Daruka Mahadevan, Paul S. Appelbaum, et al. “The Impact of Unrealistic Optimism

on Informed Consent to Participate in Early Phase Oncology Trials,” IRB: Ethics and Human Research. (September/October, 2016 )38(5):1-7.

40) Cassel, Brian J., Egidio Del Fabbro, MD, Tobias Arkenau, Irene J. Higginson, Samia Hurst, Lynn A.

Jansen, Andrew Poklepovic, Annette Rid, Jordi Rodon, Florian Strasser, Franklin G. Miller, "Phase I

cancer trials and palliative care: Antagonism, irrelevance, or synergy?," Journal of Pain and Symptom

Management. (September, 2016) 52(2):437-445.

41) Jansen, Lynn A. and Steven Wall. “Reconsidering Paternalism in Clinical Research,” Bioethics. (In

press: May, 2017).

42) Jansen, Lynn A., Paul S. Appelbaum, William MP Klein, Neil D. Weinstein, Motomo Mori,

Catherine Degnin and Daniel P. Sulmasy. “Perceptions of Control and Unrealistic Optimism in Early

Phase Cancer Trials,” Journal of Medical Ethics (JME Online First, published on August 3, 2017 as

10.1136/medethics-2016-103724).

43) Jansen, Lynn A., Paul S. Appelbaum, William MP Klein, Neil D. Weinstein, Motomo Mori,

Catherine Degnin and Daniel P. Sulmasy. “Variations in Unrealistic Optimism between Acceptors and

Decliners of Early Phase Cancer Trials,” Journal of Empirical Research on Human Research Ethics

(DOI: 10.1177/1556264617720433 | First Published July 21, 2017).

Peer-Reviewed Book Chapters:

1) Jansen, Lynn A. “The Role of The Nurse in Clinical Genetics,” in Genetics in the Clinic: Clinical,

Ethical and Social Implications for Primary Care. Edited by: Mary B. Mahowald, Victor McKusick

Angela Scheuerle and Timothy Aspinwall (New York: Mosby Inc., 2001), pp. 133-142.

2) Jansen, Lynn A. "The Ethics of Case Management in the Context of Managed Care" in A Case

Managers Survival Guide. Edited by: T. Cesta et al. (New York: Mosby Inc., 2002) pp. 324-335.

3) Jansen, Lynn A., Barbara Johnston and Daniel P. Sulmasy. “AIDS and the Ethics of Palliative Care” in

A Clinical Guide on Supportive and Palliative Care for People with HIV. Edited by: Joseph O’Neill.

(Rockville, MD: Health Resources and Administration, 2003), chapter 17.

4) Jansen, Lynn A. “Ethics Consultation at the End-of-life: Ideals, Rules, and Standards to Guide

Decision-Making,” in Ethics By Committee: A Textbook on Consultation, Organization, and Hospital

Ethics Committees. Edited by: D. Micah Hester (Rowman and Littlefield, 2007), pp. 161-186.

Invited Commentaries/Editorials:

1) Jansen, Lynn A. “Physician vs. Scientist?” The Hastings Center Report (March-April, 2008): 3.

2) Jansen, Lynn A. “Intractable End-of Life Suffering and the Ethics of Palliative Sedation: A

Commentary on Cassell and Rich,” Pain Medicine (March, 2010) Vol. 11:440-441. *With a

response/comment by Eric J. Cassell and Ben J. Rich, “Responses to Commentaries by Jansen and

Banja.”


3) Jansen Lynn A. “Voluntary Stopping of Eating and Drinking (VSED), Physician-Assisted Suicide

(PAS), or Neither in the Last Stage of Life? PAS: No; VSED: It Depends” Ann Fam Med

September/October (2015) 13:410-41.

Book Reviews:

1) Jansen, Lynn A. Review of Natural Law and Moral Inquiry: Ethics, Metaphysics and Politics in the

Work of Germain Grisez, Edited by: Robert P. George. Catholic Bioethics Quarterly (Summer, 2001).

2) Jansen, Lynn A. Review of Patient-Centered Ethics and Communication at the End of Life, David

Jeffrey (Oxford: Radcliffe Publishing, 2006). HIV Nursing May, 2006.

3) Jansen, Lynn A. Review of The Stem Cell Divide: The Facts, The Fictions, and The Fear Driving The

Greatest Scientific, Political, and Religious Debate of Our Time, Micheal Bellomo (AMACOM Press,

2006).

4) Jansen, Lynn A. “Struggling with the Dilemma of Exploitation in the Developing World”, IRB: Ethics

and Human Research July-August, 2009.

Letters:

1) Jansen, Lynn A. “Response to Peter Riga,” The National Catholic Bioethics Quarterly (Summer,

2002).

2) Jansen, Lynn A. and DP. Sulmasy, “Response to Replies on Sedation, Alimentation and Equivocation:

Careful Conversation about Care at the End of Life.” The Annals of Internal Medicine (December 17,

2002).

3) Astrow, Alan B. and Lynn A. Jansen. “Spirituality, Religion, and Medical Care: A Response to Neil

E. Scheurich,” Academic Medicine (June 16, 2003).

4) Jansen, Lynn A. and DP Sulmasy. “Response to Replies on “Bioethics, Conflicts of Interest and The

Limits of Transparency,” The Hastings Center Report (December, 2003).

5) Jansen, Lynn A. “Responses to Replies on “A Closer Look at The Bad Deal Trial: Beyond Clinical

Equipoise,” in The Hastings Center Report (January-February, 2006).

Abstracts:

1) Sulmasy, DP, Jansen, LA, Ury WA. “Might Futility Determinations Relieve Surrogates of an

Unnecessary Burden?” Journal of General Internal Medicine (April, supp. 2001) Vol. 16: 233. 2) Jansen, Lynn A and DP Sulmasy, “Terminal sedation: conceptual clarifications and moral

controversies.” Journal of General Internal Medicine 2002; 17 (supp 1):173. Accepted for presentation,

Society of General Internal Medicine Annual Meeting, Atlanta, GA (May, 2002).

3) Jansen, Lynn A. “Deliberation and Bioethics,” Genetics in Medicine (May/June, 2003).


Major National Media Attention/Coverage of Work:

1) The New York Times (March 3, 2011) “When Optimism is Unrealistic,” by, Pauline W. Chen.

2) JAMA (March 23/30, 2011- Vol. 305:1186-1187) “Patients’ Unrealistic Hopes for Cancer Trial

Benefits MAY Hinder Consent,” by Bridget M. Kuehn.

3) The Wall Street Journal (January 29, 2011) “Too Optimistic to Consent?” by Christopher Shea.

4) WSJ Blogs: Ideas Market.(January 28, 2011) False Hope? By Christopher Shea.

5) Los Angeles Times (January 25, 2011) “Unrealistic Optimism: A Problem in Clinical Trials of Cancer

Drugs,” by Karen Kaplan.

6) Medpage Today (January 27, 2011) “Cancer Trial Patients Take Rosy View of Likely Benefit Science

News,” by John Gever.

7) Science News (January 24, 2011) “Unrealistic Optimism Appears Common in Early Cancer Trials

and May Compromise Informed Consent.”

8) e! Science News (January 24, 2011) “Unrealistic Optimism appears common in early phase oncology

trials.”

9) Health News (January 27, 2011) “Are Some CANCER patients Involved in Clinical Trials Too

Optimistic? Why?”

10) Medical News Today (January 25, 2011) “Informed Consent May be Compromised by Unrealistic

Optimism in Early Cancer Trials.”

11) ASCO (American Society of Clinical Oncology) interview September 1, 2011- by Jo Cavello.

12) Portland Tribune “A Pill to Cure All Ills? It’s Just in Our Heads,” July 5, 2012- by Peter Korn.

13) IRB Advisor “Optimism bias may subvert informed consent in early phase cancer trials” May 2016

(pp.58-59) by Gary Evans.

Invited Lectures, Conference Presentations or Professorships:

International and National:

April 8, 2000. “The Economics of Race and Gender Differentials in Medicine,” Oak Forest

Hospital, Oak Forest, Illinois.

May, 2000 “Collaboration and the Limits of Publicity in Medicine: A Response to

Christopher Crenner’s Essay on Richard Cabot." American Society of Internal

Medicine Conference, Boston, MA.

October, 2001 “Terminal Suffering: Classifications, Problems and Clinical Implications.”

American Society of Bioethics and Humanities Conference. Nashville, TN.

March 13, 2003 “Deliberative Decision-Making and Genetic Counseling,” Plenary session for the

American College of Medical Genetics, San Diego, CA.

October, 2003 “Professional Integrity and The Contexts of Disclosure.” American Society of

Bioethics and Humanities Conference and the Canadian Bioethics Society,

Montreal, Canada.

March, 2004 “Ethics Charter for Pain Medicine” American Academy of Pain Medicine.

Drafted with 13 other co-authors, Chicago, IL.


October, 2007 Consensus and Independent Judgment: Or, What Can an 18th Century

Mathematician Teach Us About Ethics Consultation,” The MacLean Center of

Clinical Ethics Conference, Chicago IL.

February, 2008 “Ethics Consultation at the End-of-Life,” Association for Practical and

Professional Ethics, Austin, TX.

April 12, 2010 “The Nature and Moral Significance of Consciousness,” Conference on Music

Therapy and Disorders of Consciousness, New York, NY.

May 11, 2010 “The Problem with Optimism in Clinical Research,” Columbia University

Department of Psychiatry Grand Rounds, New York, NY.

May 27, 2010 “Therapeutic Optimism and Informed Consent in Clinical Research,” Maxim

Brettler Distinguished Lecture on Medical Humanities, North Shore Hospital,

Long Island, NY.

June 3, 2010 “The Problem with Optimism in Clinical Research,” Madeline Brill Nelson

Lecture Series in Ethics Education, Oregon Health and Science University,

Portland, OR.

April 15, 2011 “The Culture of Hope and Informed Consent,” The 21st Annual Kinsman

Conference, Eugene Oregon.

November 12, 2011 “The Problem with Optimism and Clinical Trials,” The 23rd Annual Dorothy J.

MacLean Fellows Conference,” The University of Chicago, Chicago, Illinois.

April 19, 2012 “Stewardship in Medicine: What are we talking about?” Plenary Speaker, 22nd

Annual Kinsman Conference on Medical Ethics. Portland Oregon.

May 5, 2012 “Ethical issues in human bioenhancement: Replies to Allen Buchanan,”

University of Arizona Department of Philosophy.

October 19, 2012 “Exploitation and Reasonable Parity in International Clinical Research: Replies

to Vida Panitch” Faculty Mentor, American Society of Bioethics and Humanities,

Washington DC.

April 12, 2013 “Promoting individual health and well-being through the use of biomedical

enhancements,” 23nd Annual Kinsman Conference on Medical Ethics. Ashland

Oregon.

November 15, 2013 ‘The Complexity of Clinical Intentions,” 25th Anniversary Dorothy J. MacLean

Fellows Conference on Clinical Medical Ethics. University of Chicago.

July 15-16, 2014 "Recent Developments in Phase I Oncology Trials: Implications for ethics,

palliative care, and society," The Brocher Foundation, Geneva, Switzerland.


October 23 2014 “The Optimistic Bias and High Quality Informed Consent in Research,”

Conference co-sponsored by OHRP and Children’s Hospital of Philadelphia, in

Philadelphia.

November 14, 2014 “Perceived Controllability and the Therapeutic Error in Research,” MacLean

Center- University of Chicago.

May 15, 2015 “General Beneficence and Professional Associations,” 25th Annual Kinsman

Conference on Medical Ethics. Portland, Oregon.

November 14, 2015 “Risk/Benefit Assessment, Unrealistic Optimism and Informed Consent,”

Plenary Panel talk at PRIM-R’s AER Conference (Public Responsibility in

Medicine and Research). Boston, Mass.

November 12, 2016 ‘Unrealistic Optimism and the Mindset Hypothesis’ 27th Anniversary Dorothy J.

MacLean Fellows Conference on Clinical Medical Ethics. University of Chicago

Maclean Conference.

February 7, 2017 “Optimism, Informed Consent and the Mindset Hypothesis” Department of

Philosophy, University of Oregon.

July 31, 2017 “Informed Consent in Biomedical Ethics” Department of Philosophy. Wuhan

University, China

July 31, 2017 “Unrealistic Optimism and the Mindset Hypothesis” Department of Philosophy.

Wuhan University, China

Local:

December 8, 2010 “The Ethics of Hope and Truth- Telling,” Bioethics Study Group, Oregon Health

and Science University.

March 2, 2011 “What to tell participants in clinical trials: Is consent informed?” Oregon Health

& Science University, OCTRI Human Investigators Research Lecture Series.

May 19, 2011 “Understanding Optimism in Clinical Research,” Oregon Health & Science

University, School of Nursing Research Scholar Lecture Series.

September 6, 2011 “Unrealistic Optimism in Early Phase Oncology Trials,” Grand Rounds, Oregon

Health & Science University, School of Medicine.

May 7, 2012 “Unrealistic Optimism in Early Phase Oncology Trials,” Grand Rounds, Oregon

Health & Science University, Department of Social Work.

October 17, 2012 “How should we interpret patients' understandings of risks and benefits in clinic

research,” Grand Rounds, Oregon Health & Science University, Center for

Hematologic Malignancies.

November 15, 2012 “Raising the bar in ethics and interprofessionalism,” Grand Rounds, Oregon

Health & Science University.


May 15, 2013 “Some ethical concerns about optimism in the clinic and in research,” Keynote

Speaker. Sigma Theta Tau Induction Ceremony, Oregon Health & Science

University.

December 10. 2013 “Therapeutic Misconception and Unrealistic Optimism in Clinical Research,”

Invited lecture to Masters in Clinical Research Students. Oregon Health &

Science University.

December 10, 2014 “Optimism and Consent in Clinical Research,” Invited lecture to Masters in

Clinical Research Students. Oregon Health & Science University.

December 8, 2015 “Risk/Benefit Assessment, Optimism and Informed Consent,” Invited lecture to

Masters in Clinical Research Students. Oregon Health & Science University.

February 11, 2016 "Ethical Issues in Human Subjects Research: Insights from Social Psychology,”

Grand Rounds for the Department of Psychiatry, Oregon Health & Science

University.

April 15, 2016 “Synthesizing a Keynote Address: What is the Future of Clinical Ethics in Health

Care,” (panel moderator), The Statewide Kinsman Conference in Bioethics,

Hood River, Oregon.

May 11, 2016 “Optimism and Informed Consent: Insights from Social Psychology,” Bioethics

Study Group, Oregon Health & Science University, Portland, Oregon.

November 14, 2016 “How to Analyze an Ethics Case: A Brief Introduction” Oregon Health &

Science University, School of Nursing, Portland, Oregon.

November 22, 2016 “Clinical Research, Informed Consent and the Mindset Hypothesis” Department

of Medicine Grand Rounds, Oregon Health & Science University, Portland

Oregon.

December 14, 2016 “Unrealistic Optimism and the Mindset Hypothesis,” Invited lecture for Masters

in Clinical Research, Oregon Health & Science University.

March 9, 2017 “Introduction to Ethical Reasoning” Oregon Health & Science University, School

of Nursing, Portland, Oregon.

IV. SERVICE Membership in Professional Societies: 1) American Association of Bioethics and Humanities (2000-2002). 2) American Academy of Pain Medicine, Chicago (2003-2004).

Granting Agency Review Work:


1) NIH- peer review for NIH Study Section on Societal and Ethical Issues in Research

“Revision applications to advance evidence-based research related to protections for human

subjects,” working with Karin Helmers, PhD (SRO) July-August, 2012. ZRG1 HDM-B90.

2) NIH-peer review for Jennifer Schiltz, PhD (SRO) (NIH/NCI) June 28-29, 2016 ZCA1 SRB-5 (O1)

NCI Omnibus R03.

Editorial and Ad Hoc Review Activities:

1) 2010-present: Associate Editor. Theoretical Medicine and Bioethics.

2) 2002-2010: Co-Editor. Theoretical Medicine and Bioethics.

3) 2002-present: Manuscript Reviewer

Kennedy Institute of Ethics Journal

The Hastings Center Report

Journal of Clinical Ethics

The Journal of Medical Ethics

Pain Medicine

Annals of Internal Medicine

Journal of Palliative Care

IRB: Ethics & Human Research

Bioethics

Theoretical Medicine & Bioethics

Clinical Trials

American Journal of Bioethics

British Journal of Cancer

Committees: International/National:

1) Advisory Panel Member: “Science and the Ethics of Enhancement,” National Public Broadcasting

Service. The Fred Friendly Seminar, NY (May, 2006).

2) Member: Council on Ethics, American Academy of Pain Medicine, Chicago (2003-2010).

Regional:

1) Ethics Advisory Council: The National Ovarian Cancer Coalition, Westchester Division (2001-2005).

2) Member: Health Care Ethics Committee, The New York Foundling Hospital, NY (2000-2010).

3) Co-Chair: The Annual Kinsman Conference Planning Committee, Portland Oregon (2010-Present).


Institutional:

1) Member: Integrated Scientific and Ethical Review Board (ISERB): St Vincent’s Hospital, NY (2005-

2010).

2) Member: Health Care Ethics Committee, St. Vincent’s Hospital, NY (2000-2010).

3) Co-Chair: Teaching Interprofessional Ethics: (with Phyllis Beemsterboer, Ed.D) Oregon Health and

Science University (2010-2016).

4) Member: Ethics Consultation Committee, Oregon Health & Science University (2010-present).

5) Member, OHSU Institutional Ethics Committee, Oregon Health & Science University (2010-present).

6) Ethics Course Director for Principles of Clinical Medicine, Oregon Health & Science University,

2010-2014).

7) Ethics Course Director for Transition to Residency, Oregon Health & Science University, 2010-2015).

8) Ethics Course Director for Medical School Pain Intersession, Oregon Health & Science University

(2015-present).

Departmental:

1) Member: First and Second Year Medical Education Curriculum Development Committee, New York

Medical College, NY (2000-2010).

2) Course Director: First and Second Year Medical Ethics, New York Medical College, NY (2000-2010).

3) Member: Executive Committee for the Center for Ethics in Health Care, Oregon Health & Science

University, (2010-present).

Clinical Responsibilities:

2010: Medical Ethics Consultant, Archdiocese for the City of New York.

2000-2010: Senior Medical Ethicist, St. Vincent’s Hospital, NY

2001-2005: Med/Surgical RN, St. Joseph’s Medical Center, Yonkers, NY

1999-2000: Clinical Ethics Consultant, Oak Forest Hospital. Il.


1996-1999: Pain Management RN, NYU Medical Center, NY

1992-1995: Critical Care RN, St. Luke’s/Roosevelt Hospital, NY

1989-1992: Med/Surgical RN, St. Luke’s/Roosevelt Hospital, NY

1987-1989: Neurology RN, Cedar’s Medical Center, FL.

1986-1987 Oncology RN, Imperial Point Medical Center, FL

Service and Membership of Educational Committees:

2010-2016: Co-Chair “Teaching Interprofessional Ethics Committee.” Interprofessional group of faculty

leaders at Oregon Health & Science University who work together to create an innovative ethics

curriculum that can be used to teach ethics and professionalism to students in all of the health care

professions at Oregon Health & Science University.

Professional Development in Education:

2010-present- Co-Chair “Bioethics Study Group.” Co-lead a group of faculty members in arranging ten

one hour faculty development sessions in medical ethics for faculty at Oregon Health &Science

University and the community.

VI. CONFERENCE PLANNING

2010-Present Co-Chair : “The 23rd Annual Kinsman Conference,” Portland, Oregon.

2010-Present Co-Chair: “The Daniel Labby Senior Clinicians Seminar,” OHSU Center for Ethics in

Health Care.

VII. MENTORING AND ADVISING

Mentoring responsibilities included: discussion/tutorial on selected readings, guidance on conducting and

writing up clinical ethics consultations, and assistance with research projects. Additional time was spent

in helping to prepare manuscripts for publication.

2006 Faculty mentor to third year medical student’s clinical ethics elective

2009 Faculty mentor to Mark Brubaker (MD/Resident)

2010-2011 Faculty advisor to Daniel Kennedy, D.PH (school of pharmacy)

2011-2012 Faculty mentor to Denise Mathes, RN, MPH (ethics fellowship)

2012-2013 Faculty mentor to Donna Kim, MD (ethics fellowship)

2012 Faculty mentor to Vida Panitch, PhD American Society of Bioethics and Humanities,

Washington DC. October 19-20, 2012.


2014-15 Faculty collaborator with Eran Klein, MD, PhD (Senior Scholar at Center for Ethics in

Health Care).

2015 Faculty advisor to Andy Harris, MD –Provided guidance on ethics curriculum

development for course global health ethics.

2015 Faculty advisor to Paul Gorman, MD-Provided materials and guidance on curriculum

related to the ethics of stewardship for first year medical students.

2016 Faculty advisor to Amy Vandenbrouke, JD- Provided materials and guidance on

curriculum development for ethics in radiology.

2016 Faculty mentor to Berklee Robins, MD- Reviewed and provided comments on revising

Master’s degree in Ethics thesis into a publishable manuscript.

2016 Faculty mentor to Laurel Foran, MD student thesis on ethics.

2017 Faculty collaborator with Sam Muramoto, MD- Reviewed manuscript and provided

comments for revision of manuscripts submitted and accepted for publication.

Documents

CURRICULUM VITAE NAME Lynn A. Jansen, PhD … A. Jansen, PhD CURRICULUM VITAE NAME Lynn A. Jansen, PhD DATE August 16, 2017 PRESENT POSITION AND ADDRESS Academic Rank: Madeline Brill